64848 Federal Register / Vol. 83, No. 242 / Tuesday, December 18, 2018 / Notices 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses 

per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Form 4: Section A—Quarterly Performance Report—State/ 

Territory Awardees ........................................................... 56 4 224 24 5,376 

Form 4: Section B—Quarterly Benchmark Performance 

Measures .......................................................................... 1 10 4 40 200 8,000 

Total .............................................................................. 2 56 ........................ 264 ........................ 13,376 

Amy P. McNulty, 

Acting Director, Division of the Executive 

Secretariat. 

[FR Doc. 2018–27348 Filed 12–17–18; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier: OS–0990–New] 

Agency Information Collection 

Request. 30-Day Public Comment 

Request 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment. 

DATES: Comments on the ICR must be 

received on or before January 17, 2019. 

ADDRESSES: Submit your comments to 

OIRA_submission@omb.eop.gov or via 

facsimile to (202) 395–5806. 

FOR FURTHER INFORMATION CONTACT: 

Sherrette Funn, Sherrette.Funn@hhs.gov 

or (202) 795–7714. When submitting 

comments or requesting information, 

please include the document identifier 

0990–New–30D and project title for 

reference. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: HHS 42 CFR 

subpart B; Sterilization of Persons in 

Federally Assisted Family Planning 

Projects. 

Type of Collection: Extension. 

OMB No.: 0937–0166. 

Abstract: This is a request for 

extension of a currently approved 

collection for the disclosure and 

recordkeeping requirements codified at 

42 CFR part 50, subpart B (‘‘Sterilization 

of Persons in Federally Assisted Family 

Planning Projects’’). The consent form 

solicits information to assure voluntary 

and informed consent to persons 

undergoing sterilization in programs of 

health services which are supported by 

federal financial assistance 

administered by the PHS. It provides 

additional procedural protection to the 

individual and the regulation requires 

that the consent form be a copy of the 

form that is appended to the PHS 

regulation. In 2003, the PHS 

sterilization consent form was revised to 

conform to OMB government-wide 

standards for the collection of race/ 

ethnicity data and to incorporate the 

PRA burden statement as part of the 

consent form. We are requesting a three 

year extension. 

Type of respondent: Individuals 

seeking sterilization; frequency: Once; 

prior to procedure. 

ESTIMATED ANNUALIZED BURDEN TABLE

Type of respondent Number of 

respondents 

Number 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Citizens Seeking Sterilization .......................................................................... 100,000 1 1 100,000 

Citizens Seeking Sterilization .......................................................................... 100,000 1 15/60 25,000 

Total .......................................................................................................... ........................ 2 ........................ 125,000 

Terry Clark, 

Asst. Paperwork Reduction Act Reports 

Clearance Officer, Office of the Secretary. 

[FR Doc. 2018–27366 Filed 12–17–18; 8:45 am] 

BILLING CODE 4150–34–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with grant and/or 

contract proposals applications, the 


amozie on DSK3GDR082PROD with NOTICES
Federal Register / Vol. 83, No. 242 / Tuesday, December 18, 2018 / Notices 64849 

disclosure of which would constitute a 

clearly unwarranted invasion of 

personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Improving 

the Reach and Quality of Cancer Care in 

Rural Populations 

Date: January 18, 2019. 

Time: 7:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Clifford W. Schweinfest, 

Ph.D., Scientific Review Officer, Special 

Review Branch Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W108 

Bethesda, MD 20892–9750, 240–276–6343, 

schweinfestcw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute, Special Emphasis Panel; NCI 

SPORE II (P50). 

Date: January 29–30, 2019. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Wlodek Lopaczynski, 

M.D., Ph.D., Scientific Review Officer, Office 

of the Director, Division of Extramural 

Activities, National Cancer Institute, NIH 

9609 Medical Center Drive, Room 7W514, 

Bethesda, MD 20892–9750 240–276–6340, 

lopacw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–5: NCI 

Clinical and Translational R21 and Omnibus 

R03. 

Date: February 1, 2019. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue Bethesda, MD 20814. 

Contact Person: Robert S. Coyne, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W236, Bethesda, MD 

20892–9750 240–276–5120, 

coyners@mail.nih.gov. 

Name of Committee: National Cancer 

Institute, Special Emphasis Panel; 

Quantitative Imaging Tools and Methods for 

Cancer Therapy Response Assessment. 

Date: February 1, 2019. 

Time: 11:00 a.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W640, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Saejeong J. Kim, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W640, Bethesda, MD 

20892–9750, 240–276–5179, 

saejeong.kim@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–3: NCI 

Clinical and Translational R21 and Omnibus 

R03. 

Date: February 7–8, 2019. 

Time: 4:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Ombretta Salvucci, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W264, Bethesda, MD 

20892–9750, 240–276–7286, 

salvucco@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–3: 

SBIR Contract Review. 

Date: February 13–14, 2019. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

2W032, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Eduardo E. Chufan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W254, Bethesda, MD 20892– 

9750, 240–276–7975, chufanee@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Biological 

Comparisons in Patient-Derived Models of 

Cancer. 

Date: February 22, 2019. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W236, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Robert S. Coyne, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W236, Bethesda, MD 

20892–9750, 240–276–5120, 

coyners@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–7: NCI 

Clinical and Translational R21 and Omnibus 

R03. 

Date: February 28, 2019. 

Time: 7:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Saejeong J. Kim, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W640, Bethesda, MD 

20892–9750, 240–276–2432, 

saejeong.kim@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCORP 

Research Bases. 

Date: March 5, 2019. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W032/034, Rockville, MD 20850. 

Contact Person: Michael B. Small, Ph.D., 

Scientific Review Officer, Program and 

Review Extramural Staff Training Office, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W412, Bethesda, MD 20892– 

9750, 240–276–6384, smallm@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Community Oncology Research Program— 

Community Sites. 

Date: March 7–8, 2019. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

TE406, Rockville, MD 20850. 

Contact Person: Timothy C. Meeker, M.D., 

Ph.D., Scientific Review Officer, Resources 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W606, Bethesda, MD 20892–9750, 

240–276–6464, meekert@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–1 for 

Provocative Questions. 

Date: March 7, 2019. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Hasan Siddiqui, Ph.D. , 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W240, Bethesda, MD 

20892–9750, 240–276–5122, 

hasan.siddiqui@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–6: NCI 

Clinical and Translational R21 and Omnibus 

R03. 

Date: March 7–8, 2019. 

Time: 5:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Eduardo E. Chufan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W254, Bethesda, MD 20892– 

9750, 240–276–7975, chufanee@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel SEP–4 for 

Provocative Questions. 

Date: March 14–15, 2019. 

Time: 6:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 


amozie on DSK3GDR082PROD with NOTICES
64850 Federal Register / Vol. 83, No. 242 / Tuesday, December 18, 2018 / Notices 

Place: Hilton Washington DC/Rockville 

Hotel, 1750 Rockville Pike, Rockville, MD 

20852. 

Contact Person: Clifford W. Schweinfest, 

Ph.D., Scientific Review Officer, Special 

Review Branch Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W108, 

Bethesda, MD 20892–9750, 240–276–6343, 

schweinfestcw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute, Special Emphasis Panel SEP–3 for 

Provocative Questions. 

Date: March 21, 2019. 

Time: 7:30 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington DC/Rockville 

Hotel, 1750 Rockville Pike, Rockville, MD 

20852. 

Contact Person: Hasan Siddiqui, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W240 Bethesda, MD 

20892–9750, 240–276–5122, 

hasan.siddiqui@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel TEP–9: 

Clonogenic High-Throughput Assay for AntiCancer Agents and Radiation Modulators. 

Date: March 28, 2019. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W246 Rockville, MD 20850. 

Contact Person: Jun Fang, Ph.D., Scientific 

Review Officer, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W260, Bethesda, MD, 20892–9750 

240–276–5460, jfang@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 11, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–27178 Filed 12–17–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Dental Practice-Base 

Research Network. 

Date: January 7, 2019. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIDCR Conference Room, 651 

Democracy One, 6701 Democracy Blvd., 

Bethesda, MD 20892. 

Contact Person: Guo He Zhang, MPH, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Natl Institute of Dental and 

Craniofacial Research, National Institutes of 

Health, 6701 Democracy Boulevard, Suite 

672, Bethesda, MD 20892, 

zhanggu@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: December 12, 2018. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–27277 Filed 12–17–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice To Announce Webinar To 

Request Public Input on Upcoming 

Surgeon General’s Report on Oral 

Health 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The National Institutes of 

Health (NIH), National Institute of 

Dental and Craniofacial Research 

(NIDCR), is announcing a webinar to 

provide background information 

pertaining to the commissioning of a 

new report on oral health by the 

Surgeon General and to obtain public 

input on the report. 

DATES: The webinar will be held on 

Thursday, January 10, 2019 from 12:00– 

12:30 p.m. EST. Written comments must 

be received before January 25, 2019. 

ADDRESSES: The webinar will be held by 

teleconference and online. Information 

is available at: www.nidcr.nih.gov/ 

SGReport-Oral-Health. You may submit 

written comments by: Email: NIDCRSGROH@nidcr.nih.gov; or Mail: Ms. 

Michelle Pitt, NIH/NIDCR, 31 Center 

Drive, Room 5B55, Bethesda, MD 20892. 

FOR FURTHER INFORMATION CONTACT: 

Bruce A. Dye, DDS, MPH, Dental 

Epidemiology Officer, Office of Science 

Policy and Analysis, NIH/NIDCR, 31 

Center Drive, Room 5B55, Rockville, 

MD 20892. Email: bruce.dye@nih.gov. 

SUPPLEMENTARY INFORMATION: The 

webinar will update the public on the 

status of the new Surgeon General’s 

Report on Oral Health and provide an 

opportunity for the public to submit 

comments to help guide development of 

the report. Additional information about 

the upcoming report was published in a 

previous Federal Register Notice on 

July 27, 2018, 83 FR 35664. Interested 

persons or organizations are invited to 

submit written views on oral health, 

including the importance of poor oral 

health as a public health issue, 

contemporary issues affecting oral 

health, new knowledge that may 

transform the oral health of the nation, 

and future directions. NIDCR is also 

interested in receiving examples of 

partnerships or coalitions that have 

demonstrated improvement of oral 

health and wellbeing of individuals, 

families, or communities. 

Please note that comments received, 

including any supplemental material 

provided with the comments, are part of 

the public record and subject to public 

disclosure. Do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. NIDCR will carefully 

consider all comments submitted and 

may include relevant information in the 

upcoming Surgeon General’s Report on 

Oral Health. 

Dated: December 12, 2018. 

Lawrence A. Tabak, 

Deputy Director, National Institutes of Health. 

[FR Doc. 2018–27363 Filed 12–17–18; 8:45 am] 

BILLING CODE 4140–01–P 


amozie on DSK3GDR082PROD with NOTICES